Zobrazeno 1 - 10
of 42
pro vyhledávání: '"M. S. Campo"'
Autor:
BORZACCHIELLO, GIUSEPPE, RUSSO, VALERIA, ROPERTO, FRANCO PEPPINO, NITSCH, LUCIO, ROPERTO, SANTE, F. GENTILE, A. VENUTI, M. S. CAMPO
Studies regarding the functions of the bovine papillomavirus (BPV) E5 oncoprotein in vivo are lacking and no E5- mediated mechanism underlying epithelial carcinogenesis is known. We have shown that BPV-2 DNA is present in the majority of naturally oc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3730::8e477e2bc1766d59e1e29f4e532df041
http://hdl.handle.net/11588/202229
http://hdl.handle.net/11588/202229
Publikováno v:
Journal of General Virology. 78:3001-3008
Bovine papillomavirus type 4 (BPV-4) does not possess an E6 ORF. The E6 oncoprotein of human papillomavirus (HPV) binds and degrades the tumour suppressor protein p53, thus contributing to tumour progression. Since BPV-4 lacks E6, it is unknown how t
Autor:
M E Jackson, M S Campo
Publikováno v:
Journal of Virology. 69:6038-6046
The bovine papillomavirus type 4 (BPV4) long control region (LCR) contains three consensus binding sites, E2(1), E2(2), and E2(3) (ACCN6GGT), for the viral E2 transcription factor and a fourth degenerate site, dE2 (ATCN6GGT), which lies 3 bp upstream
Publikováno v:
Journal of Virology. 69:4006-4011
The minimal enhancer in the long control region of human papillomavirus type 16 regulates cell type and constitutive expression from the promoter P97. This region contains at least four DNase I footprints (fp4e, fp5e, fp6e, and fp7e). We have shown t
Autor:
M. Cairney, M. S. Campo
Publikováno v:
Carcinogenesis. 16:1997-2001
Exposure to the flavonoid quercetin and transfection with bovine papillomavirus type 4 (BPV-4) DNA lead to oncogenic transformation of primary bovine cells. Here we show that the synergism between quercetin and BPV-4 (or its E7 oncogene) is stronger
Autor:
W F Jarrett, M S Campo
Publikováno v:
Ciba Foundation Symposium 187-Vaccines Against Virally Induced Cancers
Viruses are responsible for approximately 15% of human cancer worldwide. Human papillomavirus and hepatitis B virus are the recognized agents of cervical and liver cancer, respectively, which together constitute 80% of all virally induced cancers. If
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d88d6037f468ef61198958d865f56bf
https://doi.org/10.1002/9780470514672.ch5
https://doi.org/10.1002/9780470514672.ch5
Publikováno v:
The Journal of biological chemistry. 276(36)
The E5/E8 hydrophobic protein of BPV-4 is, at only 42 residues, the smallest transforming protein identified to date. Transformation of NIH-3T3 cells by E5/E8 correlates with up-regulation of both cyclin A-associated kinase activity and, unusually, p
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 96(2)
Modeling of disease pathogenesis and immunity often is carried out in large animals that are natural targets for pathogens of human or economic relevance. Although murine mAbs are a valuable tool in identifying certain host/pathogen interactions, pro
Autor:
M S Campo, David Fergusson
Publikováno v:
The Journal of general virology. 79
Infection by human papillomavirus type 16 (HPV-16) has been linked to cervical cancer. The transcription of viral genes in HPV-16 is partially controlled by a number of cellular transcription factors. We have previously identified a novel cellular tr
Autor:
N Kiviat, Shih-Yen Chan, J Kuypers, Kei Fujinaga, P Balaram, H Pfister, M S Campo, L. C. Ho, M O'Connor, P A Heinzel
Publikováno v:
Journal of clinical microbiology. 33(7)
We examined the genomic diversity of human papillomavirus type 6 (HPV-6) and HPV-11 isolates from different parts of the world by comparing the nucleotide sequences of part of the long control region of three reference clones and 62 HPV-6 and 40 HPV-